105 related articles for article (PubMed ID: 6259660)
1. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
Biglieri EG; Brust N; Chang B; Hirai J; Wajchenberg BL; Schambelan M
Prog Biochem Pharmacol; 1980; 17():36-43. PubMed ID: 6259660
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
[TBL] [Abstract][Full Text] [Related]
3. Adrenocorticotropin inhibition of mineralocorticoid hormone production.
Biglieri EG; Chang B; Hirai J; Brust N; Rost CR; Schambelan M
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():307s-311s. PubMed ID: 232023
[TBL] [Abstract][Full Text] [Related]
4. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Mantero F; Armanini D; Boscaro M
Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
[TBL] [Abstract][Full Text] [Related]
5. Circadian secretion of ACTH, cortisol, and mineralocorticoids in Cushing's syndrome.
Boscaro M; Scaroni C; Masarotto P; Ridolfi P; Benato M; Mantero F
Clin Exp Hypertens A; 1982; 4(9-10):1779-94. PubMed ID: 6291816
[TBL] [Abstract][Full Text] [Related]
6. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
7. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
Yasuda G; Shionoiri H; Hayashi S; Umemura S; Ikeda Y; Ishii M
Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
[TBL] [Abstract][Full Text] [Related]
8. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
10. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
Kater CE; Biglieri EG; Wajchenberg B
J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
[TBL] [Abstract][Full Text] [Related]
11. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
[No Abstract] [Full Text] [Related]
12. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
[No Abstract] [Full Text] [Related]
13. Concurrent hypercortisolism and hypermineralocorticoidism.
Hogan MJ; Schambelan M; Biglieri EG
Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
[TBL] [Abstract][Full Text] [Related]
14. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family.
D'Armiento M; Reda G; Kater C; Shackleton CH; Biglieri EG
J Clin Endocrinol Metab; 1983 Apr; 56(4):697-701. PubMed ID: 6300162
[TBL] [Abstract][Full Text] [Related]
15. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids.
Hayashi Y; Takeda Y; Kaneko K; Koyama H; Aiba M; Ikeda U; Shimada K
Endocr J; 1998 Aug; 45(4):485-91. PubMed ID: 9881897
[TBL] [Abstract][Full Text] [Related]
16. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
McCormick SD; Regish A; O'Dea MF; Shrimpton JM
Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
[TBL] [Abstract][Full Text] [Related]
17. Stimulation and suppression of the mineralocorticoid hormones in normal subjects and adrenocortical disorders.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J; Irony I
Endocr Rev; 1989 May; 10(2):149-64. PubMed ID: 2666117
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid response to low dose adrenocorticotropin infusion.
Tuck ML; Sowers JR; Asp ND; Viosca SP; Berg G; Mayes DM
J Clin Endocrinol Metab; 1981 Mar; 52(3):440-6. PubMed ID: 6257748
[TBL] [Abstract][Full Text] [Related]
19. Pseudo-Cushing's syndrome: the role of alcohol.
Elias AN; Meshkinpour H; Valenta LJ; Grossman MK
J Clin Gastroenterol; 1982 Apr; 4(2):137-9. PubMed ID: 6282953
[TBL] [Abstract][Full Text] [Related]
20. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
